Pregnancy and Breastfeeding

During pregnancy and breastfeeding, it is essential for the mother to maintain a healthy balance of her microbiota—especially the gut and vaginal microbiota. This balance helps strengthen the immune system of both the mother and the baby, as the antibodies produced by the mother can be passed to the baby through the umbilical cord. The gut and vaginal microbiota also play a key role in shaping the baby’s epigenetic markers, which influence their long-term health and susceptibility to disease throughout life. 

The maternal microbiota is the first to colonize the baby’s tissues—such as the gut, skin, and respiratory tract—from the sixth month of pregnancy through birth (especially in the case of vaginal delivery). Breast milk also provides beneficial bacteria, primarily lactic acid bacteria.

Since recent studies suggest that part of the mother’s microbiota may begin reaching the baby as early as the sixth month of pregnancy, experts emphasize the importance of caring for the maternal microbiota during the first 1,000 days—from pregnancy through the child’s first two years of life.

This is why taking probiotics during pregnancy and breastfeeding is so important. But why choose Kyojin??

Kyojin is a probiotic that, in addition to offering intestinal, neurological, and metabolic benefits, contains spores of Bacillus subtilis—a scientifically proven bacterium that protects and supports the body’s own beneficial lactic acid bacteria. This makes it an ideal ally during pregnancy and breastfeeding, helping both mother and baby from the very beginning.

Related Papers:

1. Bethany M. Henrick, y col (2021). Bifidobacteria-mediated immune system imprinting early in life. Cell 184, 3884–3898, https://doi.org/10.1016/j.cell.2021.05.030.
2. Archita Mishra, Ghee Chuan Lai,y col (2021). Microbial exposure during early human development primes fetal immune cells. Cell 184, 1–16 June 24,
3. https://doi.org/10.1016/j.cell.2021.04.039.
4. Ruairi C. Robertson, Amee R. Manges, y col (2018). The Human Microbiome and Child Growth – First 1000 Days and Beyond. Trends in Microbiol., https://doi.org/10.1016/j.tim.2018.09.008.
5. www.kyojin.com.ar.
6. Francisco M and Grau R (2018). Probiotic Bacillus subtilis prevents alpha-synuclein aggregation and extends the healthy lifespan in Parkinson disease model Caenorhabditis elegans. Advances in Alzheimer & Parkinson therapies and AAT-AD / PD Focus Meeting. Turin – Italy, 15 – 18 March.
7. Cogliati S., Clementi V., Francisco M., Crespo C., Argañaraz F., and Grau R. (2020). Bacillus subtilis delays neurodegeneration and behavioral impairment in the Alzheimer´s disease model Caenorhabditis elegans. J. Alz. Dis. 73 (3): 1035-1052. Doi: 10.3233/JAD-190837.
8. Goya M, Sue F, y col (2020). Probiotic Bacillus subtilis protects against alpha synuclein aggregation in C. elegans. Cell Rep (30)2: 367 – 380.
9. Cardinali N, Bauman C, Rodriguez Ayala F, Grau R. (2020). Two cases of type 2 diabetes mellitus successfully treated with probiotics. Clin. Case Rep.; doi 10.1002/ccr3.3354.
10. VidyaLaxme B, Rovetto A, Grau R, and Agrawal R (2014). Synergistic effects of probiotic Leuconostoc mesenteroides and Bacillus subtilis in malted ragi (Eleucine corocana) food for antagonistic activity against Vibrio cholerae and other beneficial properties. J. Food Sci. Tech. 51 (11): 3072-82. doi: 10.1007/s13197-012-0834-5.